
Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to patients with cancer, Dr. Natalie Berger said.

Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to patients with cancer, Dr. Natalie Berger said.